Usana Health Sciences, Inc., a Utah-based nutritional, skincare and dietary products manufacturer, indicates in its recently filed 8-K that it has substantially completed an internal investigation into whether the expense reimbursement policy and other practices at its Chinese affiliate, BabyCare Ltd., were compliant with the Foreign Corrupt Practices Act. The company reports that it is cooperating with the DOJ and the SEC in their investigations of the matter.
February 5, 2019
DOJ and SEC investigating nutritional supplement maker for possible FCPA violations
Related by Topic
McKinsey’s South African subsidiary resolves FCPA investigation
December 17, 2024
News Alert
BIT Mining settles with DOJ and SEC to resolve FCPA violations, while former CEO faces bribery-related charges
November 21, 2024
News Alert
Son of former Comptroller General of Ecuador pleads guilty in Odebrecht bribery scandal
November 19, 2024
News Alert